Vice President, Clinical Development, Breast Cancer
BeOne Medicines
About this role
Lead clinical development for BeOne’s oncology assets, shaping early and late-stage strategies and ensuring programs progress within scope, budget, and timelines. Serve as a senior leader responsible for building and growing the global clinical development team and collaborating with internal functions, external investigators, and key opinion leaders to advance medicines for breast and women’s cancers.
Skills
Qualifications
About BeOne Medicines
beonemedicines.comIndustries
Healthcare
BeOne Medicines, formerly BeiGene, is committed to developing innovative cancer medicines by partnering globally to serve patients everywhere.
Recent company news
TipRanksBeOne Medicines Updates on Employee Share Purchase Plan Uptake
4 hours ago
Simply Wall StAssessing BeOne Medicines (ONC) Valuation After Profit Turnaround And Optimistic 2026 Guidance
1 day ago
MarketBeatCapital International Investors Boosts Stake in BeOne Medicines Ltd. - Sponsored ADR $ONC
2 days ago
SahmBeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside
1 week ago
PR NewswireSenhwa Biosciences and BeOne Medicines Announces a Clinical Supply Agreement to Address the Challenge of Cold Tumors
Dec 10, 2025
About BeOne Medicines
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for BeOne Medicines.
Salary
$353k – $443k
per year
More jobs at BeOne Medicines
Similar Jobs
Medical Lead, Breast Cancer
American Association of Physicists in Medicine
Global Development Team Lead, Clinical Development – Lung Cancer
Revolution Medicines
Senior Manager, Capabilities Enablement
Revolution Medicines
Associate Director, Biostatistics - Late Stage
Revolution Medicines
Scientist II, Cancer Pharmacology, Translational Research
Revolution Medicines
Vice President , Global Clinical Lead - Solid Tumor
Takeda Pharmaceutical Company